Literature DB >> 22417259

New data on prostate-cancer mortality after PSA screening.

Anthony B Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22417259     DOI： 10.1056/NEJMe1200185

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  "Don't Want No Risk and Don't Want No Problems": Public Understandings of the Risks and Benefits of Non-Invasive Prenatal Testing in the United States.

Authors:  Megan Allyse; Lauren Carter Sayres; Taylor Goodspeed; Marsha Michie; Mildred K Cho
Journal:  AJOB Empir Bioeth       Date:  2015

2.  Expected population impacts of discontinued prostate-specific antigen screening.

Authors:  Roman Gulati; Alex Tsodikov; Ruth Etzioni; Rachel A Hunter-Merrill; John L Gore; Angela B Mariotto; Matthew R Cooperberg
Journal:  Cancer       Date:  2014-07-25       Impact factor: 6.860

Review 3.  Mouse models of prostate cancer: picking the best model for the question.

Authors:  Magdalena M Grabowska; David J DeGraff; Xiuping Yu; Ren Jie Jin; Zhenbang Chen; Alexander D Borowsky; Robert J Matusik
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

4.  PIRADS 2.0: what is new?

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Diagn Interv Radiol       Date:  2015 Sep-Oct       Impact factor: 2.630

5.  It's NOT FAIR! Or is it? The promise and the tyranny of evidence-based performance assessment.

Authors:  Elizabeth Bogdan-Lovis; Leonard Fleck; Henry C Barry
Journal:  Theor Med Bioeth       Date:  2012-08

6.  Leveraging the Family Influence of Women in Prostate Cancer Efforts Targeting African American Men.

Authors:  O N Okoro; C A Rutherford; S F Witherspoon
Journal:  J Racial Ethn Health Disparities       Date:  2017-08-25

7.  Prostate cancer in 2012: Paradigm shifts in prostate cancer diagnosis and treatment.

Authors:  Nathan A Hoag; S Larry Goldenberg
Journal:  Nat Rev Urol       Date:  2013-01-08       Impact factor: 14.432

Review 8.  RNA biomarkers to facilitate the identification of aggressive prostate cancer.

Authors:  Kathryn L Pellegrini; Martin G Sanda; Carlos S Moreno
Journal:  Mol Aspects Med       Date:  2015-05-27

9.  Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.

Authors:  Carlotta Buzzoni; Anssi Auvinen; Monique J Roobol; Sigrid Carlsson; Sue M Moss; Donella Puliti; Harry J de Koning; Chris H Bangma; Louis J Denis; Maciej Kwiatkowski; Marcos Lujan; Vera Nelen; Alvaro Paez; Marco Randazzo; Xavier Rebillard; Teuvo L J Tammela; Arnauld Villers; Jonas Hugosson; Fritz H Schröder; Marco Zappa
Journal:  Eur Urol       Date:  2015-03-16       Impact factor: 20.096

10.  Realizing the potential of plasma genotyping in an age of genotype-directed therapies.

Authors:  Jason J Luke; Geoffrey R Oxnard; Cloud P Paweletz; D Ross Camidge; John V Heymach; David B Solit; Bruce E Johnson
Journal:  J Natl Cancer Inst       Date:  2014-08-08       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.